Please login to the form below

Therapy Watch expands its oncology portfolio


This month Therapy Watch Oncology will be expanding its portfolio with the addition of Squamous Cell Carcinoma of the Head and Neck (SCCHN). Therapy Watch SCCHN is part of a wider portfolio which covers Chronic Lymphocytic Leukaemia (CLL), Non-Hodgkin's Lymphoma (NHL), Melanoma, Non-Small Cell Lung Cancer (NSCLC), Prostate Cancer (PCa), Renal Cell Carcinoma.

Find out more: http://www.researchpartnership.com/news/2016/10/therapy-watch-expands-oncology-portfolio/

23rd November 2016

Share

Tags

Related content